Recombinant multi-species AP2B1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AP2B1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is one of two large chain components of the assembly protein complex 2, which serves to link clathrin to receptors in coated vesicles. The encoded protein is found on the cytoplasmic face of coated vesicles in the plasma membrane. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 1300012O03Rik,ADTB2,AP-2 complex subunit beta,AP105B,AP2-BETA,AP2B1,Adaptor protein complex AP-2 subunit beta,Adaptor-related protein complex 2 subunit beta,Ap2b1,Beta-2-adaptin,Beta-adaptin,CLAPB1,Clathrin assembly protein complex 2 beta large chain,Plasma membrane adaptor HA2/AP2 adaptin beta subunit
Go
to AP2B1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP6069-Ag-1/ GM-Tg-hg-IP6069-Ag-2 | Human AP2B1 protein | Human |
GM-Tg-rg-IP6069-Ag-1/ GM-Tg-rg-IP6069-Ag-2 | Rat AP2B1 protein | Rat |
GM-Tg-mg-IP6069-Ag-1/ GM-Tg-mg-IP6069-Ag-2 | Mouse AP2B1 protein | Mouse |
GM-Tg-cynog-IP6069-Ag-1/ GM-Tg-cynog-IP6069-Ag-2 | Cynomolgus/Rhesus macaque AP2B1 protein | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP6069-Ag-1/ GM-Tg-felg-IP6069-Ag-2 | Feline AP2B1 protein | Feline |
GM-Tg-cang-IP6069-Ag-1/ GM-Tg-cang-IP6069-Ag-2 | Canine AP2B1 protein | Canine |
GM-Tg-bovg-IP6069-Ag-1/ GM-Tg-bovg-IP6069-Ag-2 | Bovine AP2B1 protein | Bovine |
GM-Tg-equg-IP6069-Ag-1/ GM-Tg-equg-IP6069-Ag-2 | Equine AP2B1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-IP6069-Ag-1/ GM-Tg-hg-IP6069-Ag-2;
GM-Tg-rg-IP6069-Ag-1/ GM-Tg-rg-IP6069-Ag-2;
GM-Tg-mg-IP6069-Ag-1/ GM-Tg-mg-IP6069-Ag-2; GM-Tg-cynog-IP6069-Ag-1/ GM-Tg-cynog-IP6069-Ag-2; GM-Tg-felg-IP6069-Ag-1/ GM-Tg-felg-IP6069-Ag-2; GM-Tg-cang-IP6069-Ag-1/ GM-Tg-cang-IP6069-Ag-2; GM-Tg-bovg-IP6069-Ag-1/ GM-Tg-bovg-IP6069-Ag-2; GM-Tg-equg-IP6069-Ag-1/ GM-Tg-equg-IP6069-Ag-2 |
Products Name | AP2B1 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | AP2B1 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AP2B1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.